Literature DB >> 23879899

Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?

Vincenzo Ficarra.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23879899     DOI： 10.1111/bju.12177

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  5 in total

Review 1.  The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.

Authors:  Vincenzo Ficarra; Marta Rossanese; Michele Zazzara; Gianluca Giannarini; Maria Abbinante; Riccardo Bartoletti; Vincenzo Mirone; Francesco Scaglione
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

2.  Prostate calculi can higher urinary retention probability and worsen uncomfortable feeling after prostate biopsy but not predict cancer.

Authors:  Meng Gu; Wenzhi Li; Qi Chen; Yanbo Chen; Mingxi Xu; Zhong Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Predictors Of Postoperative Lower Urinary Tract Symptoms Improvements In Patient With Small-Volume Prostate And Bladder Outlet Obstruction.

Authors:  Xiao-Dong Li; Yu-Peng Wu; Zhi-Bin Ke; Ting-Ting Lin; Shao-Hao Chen; Xue-Yi Xue; Ning Xu; Yong Wei
Journal:  Ther Clin Risk Manag       Date:  2019-11-07       Impact factor: 2.423

4.  Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile.

Authors:  Vittorio Canale; Aleksandra Rak; Magdalena Kotańska; Joanna Knutelska; Agata Siwek; Marek Bednarski; Leszek Nowiński; Małgorzata Zygmunt; Paulina Koczurkiewicz; Elżbieta Pękala; Jacek Sapa; Paweł Zajdel
Journal:  Molecules       Date:  2018-08-29       Impact factor: 4.411

5.  The burden of prostatic calculi is more important than the presence.

Authors:  Bumsoo Park; Seol Ho Choo
Journal:  Asian J Androl       Date:  2017 Jul-Aug       Impact factor: 3.285
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.